As states file new generic drug complaint, time is running out for DOJ
Forty-three states released a shocking new antitrust complaint detailing how major drug companies including Teva, Sandoz, Mylan, Pfizer and others allegedly fixed prices on hundreds of generic drugs. The states’ investigation...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content